Effects of pseudolaric acid B on the apoptosis, mitochondrial membrane potential and cyclooxygenase-2 expression in hepatocellular carcinoma cell line BEL-7402

World Chinese Journal of Digestology

Volumn 16, Issue 11, 2008, Pages 1151-1156

  Ju, Xiao Hua ^a   Xu, Yong Hong ^a   Li, Yan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cyclooxygenase 2; Flow cytometry; Methyl thiazolyl tetrazolium assay; Mitochondrial membrane potential; Pseudolaric acid B; Western blot

Indexed keywords

ACRIDINE ORANGE; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CYCLOOXYGENASE 2; GELATINASE B; PROSTAGLANDIN E2; PROTEIN BCL 2; PROTEIN P53; PSEUDOLARIC ACID B; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRAIN BEL 7402; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN EXPRESSION;

EID: 47249141984     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v16.i11.1151     Document Type: Article

References (29)

1. Wong VK, Chiu P, Chung SS, Chow LM, Zhao YZ, Yang BB, Ko BC. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo. Clin Cancer Res 2005; 11: 6002-6011
2. Li KS, Gu XF, Li P, Zhang Y, Zhao YS, Yao ZJ, Qu NQ, Wang BY. Effect of pseudolaric acid B on gastric cancer cells: inhibition of proliferation and induction of apoptosis. World J Gastroenterol 2005; 11: 7555-7559
3. Ko JK, Leung WC, Ho WK, Chiu P. Herbal diterpenoids induce growth arrest and apoptosis in colon cancer cells with increased expression of the nonsteroidal anti-inflammatory drug-activated gene. Eur J Pharmacol 2007; 559: 1-13
4. Gong X, Wang M, Wu Z, Tashiro S, Onodera S, Ikejima T. Pseudolaric acid B induces apoptosis via activation of c-Jun N-terminal kinase and caspase-3 in HeLa cells. Exp Mol Med 2004; 36: 551-556
5. Gong XF, Wang MW, Tashiro S, Onodera S, Ikejima T. Pseudolaric acid B induces apoptosis through p53 and Bax/Bcl-2 pathways in human melanoma A375-S2 cells. Arch Pharm Res 2005; 28: 68-72
6. Gong XF, Wang MW, Tashiro S, Onodera S, Ikejima T. Pseudolaric acid B induces human melanoma A375-S2 cell apoptosis in vitro. Zhongguo Zhongyao Zazhi 2005; 30: 55-57
7. Liu B, Chen H, Lei ZY, Yu PF, Xiong B. Studies on anti-tumour activities of pseudolaric acid-B (PLAB) and its mechanism of action. J Asian Nat Prod Res 2006; 8: 241-252
8. Tong YG, Zhang XW, Geng MY, Yue JM, Xin XL, Tian F, Shen X, Tong LJ, Li MH, Zhang C, Li WH, Lin LP, Ding J. Pseudolarix acid B, a new tubulin-binding agent, inhibits angiogenesis by interacting with a novel binding site on tubulin. Mol Pharmacol 2006; 69: 1226-1233
9. Sun MG, Williams J, Munoz-Pinedo C, Perkins GA, Brown JM, Ellisman MH, Green DR, Frey TG. Correlated three-dimensional light and electron microscopy reveals transformation of mitochondria during apoptosis. Nat Cell Biol 2007; 9: 1057-1065
10. Sareen D, Darjatmoko SR, Albert DM, Polans AS. Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Mol Pharmacol 2007; 72: 1466-1475
11. van Ginkel PR, Sareen D, Subramanian L, Walker Q, Darjatmoko SR, Lindstrom MJ, Kulkarni A, Albert DM, Polans AS. Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res 2007; 13: 5162-5169
12. She MR, Li JG, Du X, Lin W, Niu XQ, Guo KY. Involvement of mitochondria apoptotic pathway in the manumycin inducing apoptosis of U937 and HL-60. Zhonghua Xueyexue Zazhi 2007; 28: 404-406
13. Verma M, Singh SK, Bhushan S, Sharma VK, Datt P, Kapahi BK, Saxena AK. In vitro cytotoxic potential of Polyalthia longifolia on human cancer cell lines and induction of apoptosis through mitochondrial-dependent pathway in HL-60 cells. Chem Biol Interact 2008; 171: 45-56
14. Chen LH, Fang J, Li H, Demark-Wahnefried W, Lin X. Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway. Mol Cancer Ther 2007; 6: 2581-2590
15. Chen M, Guerrero AD, Huang L, Shabier Z, Pan M, Tan TH, Wang J. Caspase-9-induced mitochondrial disruption through cleavage of anti-apoptotic BCL-2 family members. J Biol Chem 2007; 282: 33888-33895
16. Wu T. Cyclooxygenase-2 in hepatocellular carcinoma. Cancer Treat Rev 2006; 32: 28-44
17. Nakamoto RH, Uetake H, Iida S, Kolev YV, Soumaoro LT, Takagi Y, Yasuno M, Sugihara K. Correlations between cyclooxygenase-2 expression and angiogenic factors in primary tumors and liver metastases in colorectal cancer. Jpn J Clin Oncol 2007; 37: 679-685
18. Park JW, Park JE, Lee JA, Lee CW, Kim CM. Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells. J Cancer Res Clin Oncol 2006; 132: 184-192
19. Fantappie O, Solazzo M, Lasagna N, Platini F, Tessitore L, Mazzanti R. P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines. Cancer Res 2007; 67: 4915-4923
20. Leng J, Han C, Demetris AJ, Michalopoulos GK, Wu T. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis. Hepatology 2003; 38: 756-768
21. Zhao QT, Yue SQ, Cui Z, Wang Q, Cui X, Zhai HH, Zhang LH, Dou KF. Potential involvement of the cyclooxygenase-2 pathway in hepatocellular carcinoma-associated angiogenesis. Life Sci 2007; 80: 484-492
22. Xie YH, Yuan MB. A relationship between cyclooxygenase-2 expression and tumor angiogenesis in experimental rat liver carcinogenesis. Zhonghua Ganzangbing Zazhi 2006; 14: 676-679
23. Ishizaki T, Katsumata K, Tsuchida A, Wada T, Mori Y, Hisada M, Kawakita H, Aoki T. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity. Int J Mol Med 2006; 17: 357-362
24. Cervello M, Montalto G. Cyclooxygenases in hepatocellular carcinoma. World J Gastroenterol 2006; 12: 5113-5121
25. Yao M, Lam EC, Kelly CR, Zhou W, Wolfe MM. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. Br J Cancer 2004; 90: 712-719
26. Pan YY, Xu SP, Jia XY, Xu HQ, Zhang Y, Rui LX, Wei W. Combination of cyclooxygenase-2 inhibitor and doxorubicin increases the growth inhibition and apoptosis in human hepatocellular carcinoma cells. Exp Oncol 2007; 29: 23-29
27. Liu NB, Peng T, Pan C, Yao YY, Shen B, Leng J. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis. World J Gastroenterol 2005; 11: 6281-6287
28. Li J, Chen X, Dong X, Xu Z, Jiang H, Sun X. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells. J Gastroenterol Hepatol 2006; 21: 1814-1820
29. Gong X, Wang M, Tashiro S, Onodera S, Ikejima T. Involvement of JNK-initiated p53 accumulation and phosphorylation of p53 in pseudolaric acid B induced cell death. Exp Mol Med 2006; 38: 428-134